Inventiva
53 hedge funds and large institutions have $217M invested in Inventiva in 2025 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.
638% more capital invested
Capital invested by funds: $29.4M → $217M (+$188M)
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
253% more funds holding
Funds holding: 15 → 53 (+38)
20.78% more ownership
Funds ownership: 3.67% → 24.45% (+21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$24.1M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$18.6M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$12.6M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.2M |
| 5 |
Millennium Management
New York
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yiheng Capital Management
San Francisco,
California
|
-$11.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AUB
51
Atlantic Union Bankshares
Glen Allen,
Virginia
| $1.4K | – | – | – |
|
52
Bank of America
Charlotte,
North Carolina
| $205 | +$204 | +44 | New |
|
53
Citigroup
New York
| $5 | +$5 | +1 | New |
|
IVA Hedge Fund Activity: Q4 2025 in Review
53 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Inventiva (IVA) for Q4 2025, worth a combined $217M — up 638% from $29.4M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new IVA positions and 0 closed out — a net gain of 38 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Samsara BioCapital, opening a new position worth an estimated $24.1M. The largest seller was Yiheng Capital Management, cutting an estimated $11.1M.
- 53 institutional investors held Inventiva (IVA) as of Q4 2025, up from 15 in Q3 2025.
- Funds reported $217M of Inventiva stock for Q4 2025, up 638% quarter-over-quarter.
- 38 funds opened new Inventiva positions in Q4 2025 and 0 closed out, a net change of +38 holders.
- The largest Inventiva buyer in Q4 2025 was Samsara BioCapital, an estimated $24.1M added.
- The largest Inventiva seller in Q4 2025 was Yiheng Capital Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q4 2025.